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Cardiovascular disease remains the most impor -tant disease of the western world. As such, many strides against cardiovascular disease have been 
made in the past decades, especially when considering 
coronary artery disease. Cardiologists went from an era 
of “watchful waiting” for a patient with an acute myo -
cardial infarction and severe coronary disease to an era 
of surgical revascularization and finally evolving to the 
new percutaneous interventional era that culminates 
with drug eluting stents. Thus, the new subspecialty 
of interventional cardiology was born. 
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Conquering the structural heart disease territory 
has long been an interventional cardiologist’s dream. 
The treatment for valvular heart disease fits perfectly the 
interventionalist's drive. It progressed from “watch ful 
waiting” to surgical correction to innovative and re -
vo lutionary percutaneous minimally invasive proce-
dures. Percutaneous pulmonary balloon valvuloplasty 
was the first percutaneous treatment for valvular heart 
disease.1 A close second, percutaneous mitral balloon 
valvuloplasty can certainly be considered one of the 
most innovative percutaneous procedures that has led 
the way for the birth of a new subspecialty: structural 
heart disease percutaneous intervention.
As with any new technological innovation, in the 
beginning, there was close scrutiny and opposition to 
change the then current “status quo”: surgical mitral 
comissurotomy. It is well established through several 
studies that have compared the immediate and early 
follow-up results of percutaneous mitral balloon valvu-
loplasty versus closed surgical commissurotomy that in 
optimal patients for these techniques there was either 
superior outcome from percutaneous mitral balloon 
valvuloplasty2,3 or no significant differences between 
both techniques.4-6 The evaluation of candidates for 
per cutaneous mitral balloon valvuloplasty requires a pre -
cise evaluation of both valve morphology and func tion 
for pre-procedure decision making and follow-up of 
patients. Patient selection is fundamental in predicting 
imme diate outcome and follow-up results of percu-
taneous mitral balloon valvuloplasty. Aguiar Filho et 
al.7, in this edition of the Revista Brasileira de Car ­
dio logia Invasiva, highlight this fundamental issue of 
patient selection as the mean Wilkins score of the 
current population was 7.6 and only 32 patients (16%) 
had a score > 8. This comes with no surprise given 
the known expertise and experience of this group of 
clinical investigators with distinct operators such as 
Es teves and Abizaid that have been involved with de -
veloping and perfecting percutaneous valve therapy 
since the early days. 
It is well defined that other patient related factors 
such as older age, presence of atrial fibrillation and 
pre-procedural mitral regurgitation can negatively affect 
percutaneous mitral balloon valvuloplasty outcomes. 
Dif ferences in age and valve morphology may ac-
count for the lower survival and event-free survival of 
per cutaneous mitral balloon valvuloplasty series from 
United States and Europe. For example, in the series 
from the Massachusetts General Hospital, 497 patients 
with echocardiographic scores < 8 and a mean age 
of 51 + 14 years have an 85% survival and a 45% 
event-free survival at 8-year follow-up. In contrast, 237 
patients with echocardiographic scores > 8 and a mean 
age of 63 + 14 years have a 55% 8-year survival, and 
only 20% of them were free of combined events at 
8-year follow-up. Regarding the current Brazilian series, 
the authors report a very long term follow-up after per -
cutaneous mitral balloon valvuloplasty in a group of 
young patients (mean age of 32 years old) with the 
great majority in normal sinus rhythm and with mitral 
regurgitation present in only 13% of the patients follo-
wed. The result of 85% probability of being free form 
restenosis at 5 years likely reflects the characteristic of 
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the patient population. However, at 10 and 20 years 
the probability of being free from restenosis declines to 
60% and 36%, respectively; and 25 patients required a 
second percutaneous mitral balloon valvuloplasty with 
27 patients undergoing surgery after restenosis was diag-
nosed. This confirms that percutaneous mitral balloon 
valvuloplasty should be the first line of treatment for 
rheumatic mitral stenosis with the understanding that 
in the “long run” some patients will require a second 
percutaneous mitral balloon valvuloplasty or mitral 
valve surgery.
Lastly, there is no unique technique of percutaneous 
mitral balloon valvuloplasty. In the current report, the 
great majority of the patients had the antegrade double-
bal loon technique. Most of the techniques of percuta-
neous mitral balloon valvuloplasty require transseptal left 
heart catheterization and use of the antegrade approach. 
There is controversy as to whether the double-balloon 
technique versus the Inoue technique of percutaneous 
mitral balloon valvuloplasty provides superior imme-
diate and long-term results. Compared with the Inoue 
technique, the double-balloon technique results in 
larger mitral valve area and lesser degree of severe 
mi tral regurgitation after percutaneous mitral balloon 
val vuloplasty, particularly in patients with echocardio-
graphic scores < 8. However, despite the difference in 
immediate outcome between both techniques, there are 
no significant differences in survival, event-free survival, 
and restenosis at long-term clinical follow-up. 
Percutaneous balloon mitral valvuloplasty has de -
finitely survived the test of time. Aguiar Fillho et al.7 
confirm once more the success of this ground breaking 
structural percutaneous intervention as first line treat-
ment for rheumatic mitral stenosis. The historical and 
well established success of percutaneous mitral balloon 
valvuloplasty should inspire the new generation of struc-
tural heart disease interventionalists to further innovate 
the field and change once and for all the landscape of 
the treatment of valvular heart disease.
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